Orion Corporation
UkraineAll drugs from this manufacturer
-
The drug is used for the prevention and treatment of persistent bronchial asthma of mild, moderate, and severe courses. It is also effective for the prevention of exercise-induced asthma.
Dosage form: powder for inhalation
Active substance Dosage budesonide 200 mcg ATC: R03BA02
-
The drug is intended for the regular treatment of bronchial asthma in adults and adolescents (from 12 years old), as well as for the symptomatic treatment of adults with chronic obstructive pulmonary disease (COPD).
Dosage form: powder for inhalation
Active substance Dosage budesonide 160 mcg/dose formoterol 4.5 mcg/dose ATC: R03AK07
-
The drug is used for the treatment of Parkinson's disease, specifically to alleviate motor impairments (instability) caused by the ineffectiveness of previous medication dosages.
Dosage form: tablets, film-coated
Active substance Dosage levodopa 50 mg carbidopa 12.5 mg entacapone 200 mg ATC: N04BA03
-
The drug is used for the treatment of Parkinson's disease, specifically to eliminate motor impairments (instability) arising from the ineffectiveness of previous levodopa dosing with dopa-decarboxylase inhibitors.
Dosage form: tablets, film-coated
Active substance Dosage levodopa 100 mg carbidopa 25 mg entacapone 200 mg ATC: N04BA03
-
The drug is used for the treatment of Parkinson's disease, specifically to eliminate motor impairments (instability) that arise due to ineffective dosing during levodopa treatment with dopamine decarboxylase inhibitors.
Dosage form: tablets, film-coated
Active substance Dosage levodopa 150 mg carbidopa 37.5 mg entacapone 200 mg ATC: N04BA03
-
The drug is used for the treatment of Parkinson's disease, specifically to eliminate motor impairments (instability) arising from ineffective levodopa dosing with dopamine decarboxylase inhibitors.
Dosage form: tablets, film-coated
Active substance Dosage levodopa 200 mg carbidopa 50 mg entacapone 200 mg ATC: N04BA03
-
The drug is used to treat Parkinson's disease or symptomatic parkinsonism. It can be used either as monotherapy in the early stages of the disease or in combination with levodopa.
Dosage form: tablets
Active substance Dosage selegiline 5 mg ATC: N04BD01
-
The drug is used for the treatment of bronchial asthma (as an adjunct to corticosteroids) and to reduce symptoms of airway obstruction in chronic obstructive pulmonary disease (COPD).
Dosage form: powder for inhalation
Active substance Dosage formoterol 12 mcg ATC: R03AC13
-
The drug is used to treat flatulence, bloating, and abdominal pain caused by gas formation, as well as for colic in infants. It is also used for preparation for radiological, ultrasound examinations, and gastroduodenoscopy, for increased gas formation after surgery, and as an agent in detergent poisoning.
Dosage form: drops, oral
Active substance Dosage dimethicone 300 mg/ml ATC: A03AX13
-
The drug is used to treat a wide range of diseases: endocrine (e.g., adrenal insufficiency), rheumatic (arthritis, osteoarthritis), allergic conditions (asthma, rhinitis, dermatitis), skin diseases, eye diseases, respiratory diseases, blood diseases, as well as certain oncological and neurological conditions.
Dosage form: tablets
Active substance Dosage methylprednisolone 16 mg ATC: H02AB04
-
The drug is used for the short-term treatment of severe acute decompensated chronic heart failure when conventional therapy is ineffective or when inotropic support is required.
Dosage form: concentrate for infusion solution
Active substance Dosage levosimendan 2.5 mg/ml ATC: C01CX08
-
The drug is used for the treatment and prevention of deep vein thrombosis and pulmonary embolism. It is also prescribed for the secondary prevention of myocardial infarction, prevention of thromboembolic complications after infarction, or in patients with atrial fibrillation and heart valve damage.
Dosage form: tablets
Active substance Dosage warfarin 3 mg ATC: B01AA03
-
The drug is used for the treatment and prevention of deep vein thrombosis and pulmonary embolism. It is also prescribed for the secondary prevention of myocardial infarction, the prevention of thromboembolic complications after an infarction, as well as in patients with atrial fibrillation or prosthetic heart valves.
Dosage form: tablets
Active substance Dosage warfarin 5 mg ATC: B01AA03